Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Celldex Therapeutics, Inc. (CLDX)

Biohaven Ltd. and Celldex Therapeutics, Inc. are both Biotechnology companies. Biohaven Ltd. and Celldex Therapeutics, Inc. are of similar size ($2.2B and $2.1B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against −88.3%. Biohaven Ltd. has the higher net margin (0.00% vs −33,883.8%) and the lower return on invested capital (−6,659.9% vs 0.00%). Across the 16 metrics below, Biohaven Ltd. leads on 10 and Celldex Therapeutics, Inc. on 6.

Valuation

Metric BHVN CLDX Biotechnology median
P/E n/m n/m 10.26
P/S 2.13 2,497.55 9.18
P/B n/m 3.10 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.23 1,691.39 8.98
Earnings yield (27.50%) (15.28%) (34.89%)
Free cash flow yield (23.27%) (10.93%) (24.52%)

Profitability

Metric BHVN CLDX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (36,733.82%) 0.00%
Net margin 0.00% (33,883.77%) 0.00%
Free cash flow margin 0.00% (27,294.81%) 0.00%
Return on equity 940.46% (43.88%) (50.12%)
Return on assets (161.32%) (40.76%) (45.60%)
Return on invested capital (6,659.91%) 0.00% 0.00%

Growth

Metric BHVN CLDX Biotechnology median
Revenue growth (TTM) 425.20% (88.27%) 6.26%
EPS growth (last fiscal year) 26.08% (59.18%) 29.88%
Revenue growth, 5-year CAGR — (26.93%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN CLDX Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 3.05 11.82 4.89
Net debt to EBITDA 0.11 1.78 1.01

Dividend

Metric BHVN CLDX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BHVN CLDX Biotechnology median
Market cap 2.10b 2.22b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack